Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: Effect on microstructure and physical parameters

Pharmaceutical Research

Volumn 25, Issue 1, 2008, Pages 227-236

  Mehta, S K ^a   Kaur, Gurpreet ^a   Bhasin, K K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Controlled release; Drug delivery potential; Isoniazid; Microemulsion; Solubility; Stability; Structural changes

Indexed keywords

ALCOHOL; ISONIAZID; OLEIC ACID; PHOSPHATE; POLYSORBATE 80; TUBERCULOSTATIC AGENT;

ARTICLE; COLLOID; CONDUCTANCE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MICROEMULSION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE TENSION; VISCOSITY;

ANTITUBERCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; ELECTRIC CONDUCTIVITY; EMULSIONS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; ISONIAZID; MAGNETIC RESONANCE SPECTROSCOPY; MICROSPHERES; MOLECULAR CONFORMATION; PARTICLE SIZE; POLYSORBATES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE TENSION; VISCOSITY;

EID: 38049110308     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9355-8     Document Type: Article

References (49)

1. W. A. Ristsehel. Microemulsions for improved peptide absorption from the gastrointestinal tract. Method find. Exp. Clin. 13:205-220 (1991).
2. J. M. Sareiaux, L. Acar, and P. A. Sado. Using microemulsion formulations for oral delivery of therapeutic peptides. Int. J. Pharm. 120:127-136 (1995).
3. P. P. Constantinides. Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12:1561-1572 (1995).
4. 10: formulation development and bioavailablity assessment. Int. J. Pharm. 212:233-246 (2001).
5. C. K. Kim, Y. J. Cho, and Z. J. Gao. Preparation and evaluation of biphenyl dimetyl dicarboxylate microemulsons for oral delivery. J. Control. Release 70:149-155 (2001).
6. K. Kawakami, T. Yoshikawa, T. Hayashi, Y. Nishihara, and K. Masuda. Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J. Control. Release 81:75-82 (2002).
7. C. W. Pouton. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25:47-58 (1997).
8. H. N. Bhargava, A. Narurkar, and I. M. Lieb. Using microemulsion for drug delivery. Pharm. Technology 1:46-54 (1987)
9. M. Trotta, S. Morel, and M. R. Gasco. Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsion. Pharmazie 52:50-53 (1997).
10. M. A. Bolzinger, T. C. Carduner, and M. C. Poelman. Bicontinuous sucrose ester microemulsion: a new vehicle for tropical delivery of niflumic acid. Int. J. Pharm. 176:39-45 (1998).
11. M. Kreigaard, M. J. Kemme, J. Burggraaf, R. C. Schoemaker, and A. F. Cohen. Influence of microemulsion vehicle on a cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm. Res. 18:593-599 (2001).
12. M. Kreigaard, E. J. Pederson, and J. W. Jaroszewski. NMR characterization and transdermal drug delivery potential of microemulsion system. J. Control. Release 69:421-433 (2000).
13. L. Lehmann, S. Keipert, and M. Gloor. Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur. J.Pharm. Biopharm. 52:129-136 (2001).
14. K. Kriwet, and C. C. Muller-Goymann. Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int. J. Pharm. 125:231-242 (1995).
15. M. Trotta. Infleunce of phase transformation on indomethacin release from microemulsions. J. Control. Release 60:399-405 (1999).
16. M. E. Dalmora, and A. G. Oliveria. Inclusion complex of peroxicam with β-cyclodextrin and incorporation in heaxdecyltrimethyl ammonium bromide based microemulsions. Int. J. Pharm. 184:157-164 (1999).
17. F. Pattarino, E. Marengo, and M. R. Gasco. Experimental design and partial least square in the study of complex mixtures: microemulsions as drug carriers. Int. J. Pharm. 91:157-165 (1993).
18. P. Kumar and K. L. Mital. Handbook of microemulsion: science and technology, Marcel Dekker, New York, 1999.
19. F. Podlogar, M. Gašperlin, M. Tomšič, A. Jamnik, and M. Bešter-Rogač. Structural characterization of water-Tween 40®-Imwitor 308®-isopropyl myristate using different experimental methods. Int. J. Pharm. 276;115-128 (2004).
20. A. Lopez, F. Linares, C. Cortell, and M. Herraez. Comparative enhancer effects of Span 20® with Tween 20® and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicities. Int. J. Pharm. 202:133-140 (2000).
21. J.-Y. Fang, S.-Y. Yu, P.-C. Wu, Y.-B. Huang, and Y.-H. Tsai. In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. 215:91-99 (2001).
22. A. H. Kibbe. Handbook of Pharmaceutical Excipients, 3rd ed. Pharmaceutical, London, 2000.
23. M. J. Lawerence and G. D. Rees. Microemulsion based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45:89-121 (2000).
24. J. Kreuter. Nanoparticles. In Colloidal Drug Delivery Systems, Marcel Dekker, New York (1994).
25. A. T. Florence and D. Attwood. Physicochemical Principles of Pharmacy, 3rd ed. Macmillan, London.
26. 2O system. Colloid. Polym. Sci. 284:468-474 (2006).
27. L. C. du Toit, V. Pillay, and M. P. Danckwerts. Tuberculosis chemotherapy: current drug delivery approaches. Resp. Res. 7:118-136 (2006).
28. J. L. Lando and H. T. Oakley. Tabulated correction factors for the drop-weight-volume determination of surface and interracial tensions. J. Colloid Interface Sci. 25:526-528 (1967).
29. L. K. Pershing, G. E. Parry, and L. D Lambert. Disparity of in vitro and in vivo oleic acid-enhanced β-estradiol percutaneous absorption across human skin. Pharm. Res. 10:1745-1750 (1993).
30. H. Tanojo, H.E. Junginger, and H.E. Boddé. In vivo human skin permeability enhancement by oleic acid: transepidermal water loss and Fourier-transform infrared spectroscopy studies. J. Control. Release 47:31-39 (1997).
31. S. Peltola, P. J. Saarinen-Savolainen, T. M. Suhonen, and A. Urtti. Microemulsions for topical delivery of estradiol. Int. J. Pharm. 254:99-107 (2003).
32. N. Subramanium, S. Ray, S. K. Ghosal, R. Bhadra, and S. P. Moulik. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull. 27:1993-1999 (2004).
33. F. F. Lv, L.Q. Zheng, and C.-H. Tung. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int. J. Pharm. 301:237-246 (2005).
34. K. V. Schubert and E. W. Kaler. Nonionic microemulsions. Phys. Chem. 100:190-205 (1996).
35. R. G. Alany, T. Rades, S. Agatonovic-Kustrin, N. M. Davies, and I. G. Tucker. Effects of alcohols and diols on the phase behavior of quaternary systems. Int. J. Pharm. 196:141-145 (2000).
36. S. K. Mehta and K. Bala. Tween based microemulsions: a percolation view. Fluid Phase Equilibra 172:197-209 (2000).
37. G. S. Grest, I. Webman, and S. A. Safran. Dynamic percolation in microemulsions. Phys. Rev. A 33(4):2842-2845 (1986).
38. B. Lagourette, J. Peyrelasse, C. Boned, and M. Clausse. Percolative conduction in microemulsion type systems. Nature 281:60-62 (1979).
39. S. K. Mehta and K. Bala. Volumetric and transport properties in microemulsions and the point of view of percolation theory. Phys. Rev. E. 51:5732-5737 (1995).
40. K. E. Bennett, J. C. Hatfield, H. T. Davis, C. W. Macosko, and L. E. Seriven. Viscosity and conductivity of microemulsions. In: Robb, I. D. (ed.), Microemulsions, Plenum, New York, pp 65-84 (1982).
41. R. K. Mitra and B. K. Paul. Physicochemical investigations of microemulsification of eucalyptus oil and water using mixed surfactants (AOT + Brij35) and butanol. J. Colloid Inter. Sci. 283:565-577 (2005)
42. M. E. Leser, W. C. Evert, and W. G. M. Agterof. Phase behaviourof lecithin-water-alcohol-triacylglycerol mixtures. Colloids Surf. A., 116:293-308 (1996).
43. F. Aliotta, P. Migliardo, D. I. Donato, V. Turco Liveri, E. Bardez, and B. Larry. Local hydration effects in reversed micellar aggregation. Progr. Colloid Polym. Sci. 89:258-262 (1992).
44. V. Arcoleo, M. Goffredi, V. Turco Liveri. Physicochemical characterization of copper (II) bis(2-ethylhexyl) sulfosuccinate reversed micelles. J. Colloid Int. Sci. 198:216-223 (1998).
45. H. M. El-Laithy. Preparation and physicochemical characterization of dioctyl sodium dulfosuccinate (Aersol OT) microemulsion for oral drug delivery. AAPS PharmSciTech 4(Article 11):1-10 (2003).
46. H. Dai, Q. Chen, H. Qin, Y. Guan, D. Shen, Y. Hua,Y. Tang, and J. Xu. A temperature-responsive copolymer hydrogel in controlled drug delivery. Macromolecules 39:6584-6589 (2006)
47. N. Wakiyama, K. Juni, and M. Nakano. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chem. Pharm. Bull. 29:3363-3368 (1981).
48. L. Zhang, X. Sun, and Z.-R. Zhang. An investigation on liver-targeting microemulsions of norcantharidin. Drug Deliv. 12:289-295 (2005).
49. C. Washington. Drug release from microdisperse systems: a critical review. Int. J. Pharm. 58:1-12 (1990).